Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Structural and functional study of HIV-1 Tat interaction with 7SK RNP

Award Number: F32AI200648
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 06/01/2026
PERIOD OF PERFORMANCE END DATE: 05/31/2029

Group Awards By:

View Award Description

Structural and functional study of HIV-1 Tat interaction with 7SK RNP - Project Summary Despite decades of research effort, the HIV-1 retrovirus remains a major global public health crisis. To date, there is no cure for HIV-1, with an infected individual requiring continuous antiretroviral therapy (ART) to thwart the onset of AIDS. When ART is ceased, there is a rebound of viremia that originates from the pool of latently infected CD4+ T cells. This rebound within a latently infected cell begins with transcriptional reactivation of the HIV-1 genome, and the Transactivator of transcription (Tat) protein lies at the heart of HIV-1 gene expression. Tat activates gene expression by recruiting the kinase Positive Transcription Elongation Factor b (P-TEFb) to a paused RNA Polymerase II (RNAP II), ultimately promoting RNAP II pause release. Specifically, Tat recruits P- TEFb to the nascent Transactivation Response (TAR) RNA element, with Tat positioning P-TEFb for phosphorylation of the RNAP II C-terminal domain and transcription factors to promote RNAP II pause escape. Importantly, a major cellular reservoir of P-TEFb is held inactive by the dimeric Hexim1 (or less commonly Hexim2) protein within the 7SK ribonucleoprotein (RNP), and prior work supports that Tat “hijacks” P-TEFb from 7SK RNP for subsequent P-TEFb recruitment to TAR. However, the molecular mechanisms underpinning this hijacking remain uncharacterized, posing a fundamental barrier to targeting Tat transactivation as an HIV-1 eradication strategy. A potential route to Tat removal of P-TEFb is by competing with Hexim1 for 7SK RNA binding, since one of the Hexim1 binding sites on 7SK RNA mimics the Tat recognition site on TAR RNA. Therefore, Aim 1 proposes to define the competition between Tat and Hexim1 for binding to 7SK RNA in vitro by NMR, ITC, and EMSA experiments, building upon recent work from the Feigon lab that successfully employed these same methods to identify Hexim1 binding sites on and affinities for 7SK RNA. Aim 2 proposes to purify and biochemically characterize a Tat-bound 7SK RNP from mammalian cells, since this complex is a proposed intermediate prior to Tat–P-TEFb handover to TAR. Specifically, the complex will be characterized with mass photometry, mass spectrometry, and SHAPE-/DMS-MaP. Lastly, Aim 3 describes how the structure of a Tat– 7SK RNP will be determined by cryoEM and how structure-derived hypotheses will be tested on Tat transactivation in a cell line model of HIV-1 latency. The proposed work is supported by the Feigon lab’s excellent track record of combining NMR and cryoEM to study challenging, dynamic RNPs and, all the necessary facilities and equipment are available to execute this work. Together, the goal of this fellowship proposal is to uncover the structural and mechanistic basis of Tat “hijacking” of P-TEFb from the 7SK RNP, providing new insights to aid design of HIV-1 therapeutics and offering a rich training in structural biology methods.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $76,300 )
2026	2026	UNIVERSITY OF CALIFORNIA, LOS ANGELES	10889 WILSHIRE BLVD STE 700	LOS ANGELES	CA	90024	LOS ANGELES	USA	Allergy and Infectious Diseases Research	001	1	5/7/2026	NEW	$0
2026	2026	UNIVERSITY OF CALIFORNIA, LOS ANGELES	10889 WILSHIRE BLVD STE 700	LOS ANGELES	CA	90024	LOS ANGELES	USA	Allergy and Infectious Diseases Research	000	1	5/7/2026	NEW	$76,300
														Subtotal = $76,300

Grand Total All Awards = $76,300

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Structural and functional study of HIV-1 Tat interaction with 7SK RNP

Award Number: F32AI200648

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 06/01/2026

PERIOD OF PERFORMANCE END DATE: 05/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer